88IV - PR Newswire Asia's news


Antengene to Present Latest Preclinical Results of Novel Cos-TCE Platform in Rapid Oral Abstract Presentation at SITC 2026 SHANGHAI and HONG KONG , Oct. 3, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to ... 2026-10-03T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ascletis' ASC36_35FDC Demonstrated Potential for Once-Monthly to Once-Quarterly Dosing and Robust Weight-Loss in Preclinical Studies Presented at EASD 2026 HONG KONG , Oct. 2, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announced the presentation of key preclinical data for its ASC36_35FDC (ASC36_35 co-formulation) ... 2026-10-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026 Late-breaking Phase III MASCOT oral presentation will characterize the clinical profile and diversity of participants in Lundbeck's ongoing global Phase III trial investigating amlenetug in multiple system ... 2026-10-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs Includes worldwide license to ABO2203, Abogen's mRNA-encoded CD19xCD3 T-Cell Engager ... 2026-10-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
I Peace Selected as a TOP 10 Awardee for the "Top 10 Longevity Breakthrough Awards 2026" PALO ALTO, Calif. , Oct. 2, 2026 /PRNewswire/ -- I Peace Inc., a biotech company pioneering induced pluripotent stem cell (iPS cell ) technologies for regenerative medicine and longevity, today announced ... 2026-10-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Bambusa Therapeutics Initiates Subcutaneous Dosing of BBT001 in Atopic Dermatitis, Following Compelling Intravenous Proof-of-Concept Data First patient dosed as Bambusa expands global development of its long-acting bispecific antibody targeting both IL-4Rα and IL-31 ... 2026-10-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth SINGAPORE , Oct. 1, 2026 /PRNewswire/ -- Emerald Clinical Trials , a leading global clinical research organization anchored in Asia-Pacific, today announced the appointment of Michael Stibilj ... 2026-10-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal's ... 2026-09-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Phrontline Biopharma Doses First Patient in Global Phase I/II Trial of TJ102, an FRα × CDH6 Bispecific Dual-Payload ADC First clinical program built on Phrontline's DLP1 branched dual-payload linker platform ... 2026-09-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
The 94th CMEF, the World's Leading Medical Device Industry Event, Set to Open in Beijing Oct. 21-24 BEIJING , Sept. 30, 2026 /PRNewswire/ -- The 94th China International Medical Equipment Fair (CMEF) and concurrent events—including ICMD, covering medical device design and manufacturing; CRS, focusing ... 2026-09-30T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology